112 related articles for article (PubMed ID: 10585881)
1. Metabolism, mitochondrial uptake and toxicity of 2', 3'-dideoxycytidine.
Rossi L; Serafini S; Schiavano GF; Casabianca A; Vallanti G; Chiarantini L; Magnani M
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):915-20. PubMed ID: 10585881
[TBL] [Abstract][Full Text] [Related]
2. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
Törnevik Y; Eriksson S
Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
[TBL] [Abstract][Full Text] [Related]
3. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
Hao Z; Stowe EE; Ahluwalia G; Baker DC; Hebbler AK; Chisena C; Musser SM; Kelley JA; Perno CF; Johns DG
Drug Metab Dispos; 1993; 21(4):738-44. PubMed ID: 7690699
[TBL] [Abstract][Full Text] [Related]
4. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
[TBL] [Abstract][Full Text] [Related]
5. Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro.
Starnes MC; Cheng YC
J Biol Chem; 1987 Jan; 262(3):988-91. PubMed ID: 2433280
[TBL] [Abstract][Full Text] [Related]
6. In vitro toxicity and metabolism of 2',3'-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivity.
Brandi G; Rossi L; Schiavano GF; Salvaggio L; Albano A; Magnani M
Chem Biol Interact; 1991; 79(1):53-64. PubMed ID: 1647888
[TBL] [Abstract][Full Text] [Related]
7. 2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line.
Magnani M; Brandi G; Casabianca A; Fraternale A; Schiavano GF; Rossi L; Chiarantini L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):115-23. PubMed ID: 7492300
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs.
Faraj A; Agrofoglio LA; Wakefield JK; McPherson S; Morrow CD; Gosselin G; Mathe C; Imbach JL; Schinazi RF; Sommadossi JP
Antimicrob Agents Chemother; 1994 Oct; 38(10):2300-5. PubMed ID: 7530932
[TBL] [Abstract][Full Text] [Related]
9. Effects of 2',3'-dideoxycytidine and 2',3'-dideoxycytidine 5'-triphosphate on phospholipid metabolism in permeabilized rat hepatocytes.
De Groote K; Naesens L; Balzarini J; Baes MI; Declercq PE
Biochem Pharmacol; 1997 Sep; 54(6):713-9. PubMed ID: 9310348
[TBL] [Abstract][Full Text] [Related]
10. Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs.
Feng JY; Johnson AA; Johnson KA; Anderson KS
J Biol Chem; 2001 Jun; 276(26):23832-7. PubMed ID: 11328813
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes.
Szebeni J; Wahl SM; Betageri GV; Wahl LM; Gartner S; Popovic M; Parker RJ; Black CD; Weinstein JN
AIDS Res Hum Retroviruses; 1990 May; 6(5):691-702. PubMed ID: 2163269
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of (alpha-P-borano)-2',3'-dideoxycytidine 5'-triphosphate into DNA by drug-resistant MMLV reverse transcriptase and Taq DNA polymerase.
Dobrikov MI; Sergueeva ZA; Shaw BR
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1651-5. PubMed ID: 14565487
[TBL] [Abstract][Full Text] [Related]
13. Cytidine-5'-diphosphocholine affects CTP-phosphocholine cytidylyltransferase and lyso-phosphatidylcholine after transient brain ischemia.
Adibhatla RM; Hatcher JF; Dempsey RJ
J Neurosci Res; 2004 May; 76(3):390-6. PubMed ID: 15079868
[TBL] [Abstract][Full Text] [Related]
14. The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2',3'-dideoxycytidine.
Chen CH; Cheng YC
J Biol Chem; 1992 Feb; 267(5):2856-9. PubMed ID: 1310674
[TBL] [Abstract][Full Text] [Related]
15. 2',3'-Dideoxycytidine induced drug resistance in human cells.
Magnani M; Gazzanelli G; Brandi G; Casabianca A; Fraternale A; Chiarantini L; Rossi L
Life Sci; 1995; 57(9):881-7. PubMed ID: 7630317
[TBL] [Abstract][Full Text] [Related]
16. Cytostatic effects of 2',3'-dideoxyribonucleosides on transformed human hemopoietic cell lines.
Blakley RL; Harwood FC; Huff KD
Mol Pharmacol; 1990 Feb; 37(2):328-32. PubMed ID: 2154678
[TBL] [Abstract][Full Text] [Related]
17. Chiral influences of feedback inhibition with dCTP on murine deoxycytidine kinase.
Tomikawa A; Yamaguchi T; Kawaguchi T; Shudo K; Saneyoshi M
Nucleic Acids Symp Ser; 1997; (37):181-2. PubMed ID: 9586059
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vesicular stomatitis virus RNA synthesis by 2',3'-dideoxycytidine 5'-triphosphate.
Patton JT; Davis NL; Wertz GW
J Gen Virol; 1983 Mar; 64 Pt 3():743-8. PubMed ID: 6298355
[TBL] [Abstract][Full Text] [Related]
19. 2',3'-dideoxycytidine permeation of the human erythrocyte membrane.
Magnani M; Bianchi M; Rossi L; Stocchi V
Biochem Int; 1989 Aug; 19(2):227-34. PubMed ID: 2554906
[TBL] [Abstract][Full Text] [Related]
20. The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species.
Balzarini J; Pauwels R; Baba M; Herdewijn P; de Clercq E; Broder S; Johns DG
Biochem Pharmacol; 1988 Mar; 37(5):897-903. PubMed ID: 2830886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
